REGENXBIO (RGNX) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

RGNX is expected to report earnings to rise 4.76% to -110 cents per share on November 06

Q3'24

Est.

$-1.10

Q2'24

Beat

by $0.24

Q1'24

Missed

by $0.12

Q4'23

Missed

by $0.16

Q3'23

Beat

by $0.04

The last earnings report on August 01 showed earnings per share of -104 cents, beating the estimate of -128 cents. With 417.04K shares outstanding, the current market capitalization sits at 533.77M.

View a ticker or compare two or three

Compare

RGNX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For RGNX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for RGNX (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of gene therapy treatments

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

9804 Medical Center Drive

Phone

+1 240 552-8181

Employees

344

Web

https://www.regenxbio.com